Cellular immunity against SARS-CoV-2 is predominantly boosted in vaccinated individuals with no history of infection
| Errataetall: |
CommentOn: J Infect. 2022 May;84(5):e45-e47. - PMID 35278482 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:87 |
|---|---|
| Enthalten in: |
The Journal of infection - 87(2023), 2 vom: 19. Aug., Seite e31-e32 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Favresse, Julien [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 14.07.2023 Date Revised 21.02.2024 published: Print-Electronic CommentOn: J Infect. 2022 May;84(5):e45-e47. - PMID 35278482 Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.jinf.2023.05.014 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM357137132 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM357137132 | ||
| 003 | DE-627 | ||
| 005 | 20240222091257.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jinf.2023.05.014 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1301.xml |
| 035 | |a (DE-627)NLM357137132 | ||
| 035 | |a (NLM)37211218 | ||
| 035 | |a (PII)S0163-4453(23)00292-X | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Favresse, Julien |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Cellular immunity against SARS-CoV-2 is predominantly boosted in vaccinated individuals with no history of infection |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 14.07.2023 | ||
| 500 | |a Date Revised 21.02.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentOn: J Infect. 2022 May;84(5):e45-e47. - PMID 35278482 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Comment | |
| 650 | 7 | |a Antibodies, Viral |2 NLM | |
| 700 | 1 | |a Cabo, Julien |e verfasserin |4 aut | |
| 700 | 1 | |a Douxfils, Jonathan |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The Journal of infection |d 1982 |g 87(2023), 2 vom: 19. Aug., Seite e31-e32 |w (DE-627)NLM012791822 |x 1532-2742 |7 nnns |
| 773 | 1 | 8 | |g volume:87 |g year:2023 |g number:2 |g day:19 |g month:08 |g pages:e31-e32 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jinf.2023.05.014 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 87 |j 2023 |e 2 |b 19 |c 08 |h e31-e32 | ||